Antonios Bayas

3.5k total citations
52 papers, 1.2k citations indexed

About

Antonios Bayas is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Antonios Bayas has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 13 papers in Immunology and 12 papers in Neurology. Recurrent topics in Antonios Bayas's work include Multiple Sclerosis Research Studies (24 papers), Polyomavirus and related diseases (11 papers) and Immunotherapy and Immune Responses (7 papers). Antonios Bayas is often cited by papers focused on Multiple Sclerosis Research Studies (24 papers), Polyomavirus and related diseases (11 papers) and Immunotherapy and Immune Responses (7 papers). Antonios Bayas collaborates with scholars based in Germany, United States and Austria. Antonios Bayas's co-authors include Peter Rieckmann, Markus Naumann, Ralf Gold, Vera Hummel, Monika Christ, Boris Kallmann, Niels Kruse, Mariusz Stasiołek, Krzysztof Selmaj and Lars Behrens and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Antonios Bayas

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonios Bayas Germany 19 459 301 224 216 210 52 1.2k
B. C. Kieseier Germany 15 597 1.3× 233 0.8× 271 1.2× 222 1.0× 285 1.4× 62 1.2k
Neil Minton United States 11 462 1.0× 155 0.5× 146 0.7× 208 1.0× 133 0.6× 24 818
Sarah Shapiro Israel 17 292 0.6× 332 1.1× 119 0.5× 334 1.5× 235 1.1× 34 1.3k
Amanda Cox United States 18 809 1.8× 564 1.9× 470 2.1× 163 0.8× 316 1.5× 45 1.8k
Giorgia Teresa Maniscalco Italy 15 447 1.0× 438 1.5× 195 0.9× 277 1.3× 159 0.8× 64 1.1k
Dan Lehmann Israel 19 351 0.8× 598 2.0× 126 0.6× 169 0.8× 151 0.7× 36 1.2k
Hirofumi Ochi Japan 24 654 1.4× 649 2.2× 468 2.1× 323 1.5× 194 0.9× 89 1.8k
Sandrine Wiertlewski France 19 740 1.6× 428 1.4× 447 2.0× 96 0.4× 140 0.7× 48 1.2k
Jacqueline Yaouanq France 20 592 1.3× 269 0.9× 204 0.9× 188 0.9× 148 0.7× 39 1.6k
Begoña Oliver‐Martos Spain 17 262 0.6× 287 1.0× 251 1.1× 229 1.1× 188 0.9× 63 959

Countries citing papers authored by Antonios Bayas

Since Specialization
Citations

This map shows the geographic impact of Antonios Bayas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonios Bayas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonios Bayas more than expected).

Fields of papers citing papers by Antonios Bayas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonios Bayas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonios Bayas. The network helps show where Antonios Bayas may publish in the future.

Co-authorship network of co-authors of Antonios Bayas

This figure shows the co-authorship network connecting the top 25 collaborators of Antonios Bayas. A scholar is included among the top collaborators of Antonios Bayas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonios Bayas. Antonios Bayas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bayas, Antonios, et al.. (2024). Mirror movements in multiple sclerosis -a clinical, electrophysiological, and imaging study. BMC Neurology. 24(1). 326–326.
2.
Naumann, Markus, et al.. (2024). First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report. Therapeutic Advances in Neurological Disorders. 17. 4233588775–4233588775. 1 indexed citations
3.
Huhn, Konstantin, et al.. (2023). Breastfeeding in Mothers with Multiple Sclerosis: The German Experience. Breastfeeding Medicine. 18(3). 241–245. 2 indexed citations
4.
Bayas, Antonios, Monika Christ, Simon Faissner, et al.. (2023). Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials. Therapeutic Advances in Neurological Disorders. 16. 4213427924–4213427924. 14 indexed citations
5.
Meuth, Sven G., Antonios Bayas, Boris Kallmann, et al.. (2022). Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4. Expert Opinion on Pharmacotherapy. 23(13). 1503–1510. 21 indexed citations
6.
7.
Bayas, Antonios, et al.. (2021). Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet. 397(10285). e11–e11. 105 indexed citations
8.
9.
Huhn, Konstantin, Antonios Bayas, Benedikt Frank, et al.. (2018). Alemtuzumab as rescue therapy in a cohort of 50 relapsing–remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study. Journal of Neurology. 265(7). 1521–1527. 29 indexed citations
10.
11.
Linker, Ralf A., Antonios Bayas, Kerstin Hellwig, et al.. (2016). Safety and Efficacy of Alemtuzumab after Switching from Fingolimod: A German Multi-Center Experienceover One Year (P6.184). Neurology. 86(16_supplement). 1 indexed citations
12.
13.
Schroeter, Michael, Claudia Kaiser, Christoph Kleinschnitz, et al.. (2015). The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients. Scientific Reports. 5(1). 14265–14265. 8 indexed citations
14.
Kornek, Barbara, Fahmy Aboul‐Enein, Kevin Rostásy, et al.. (2013). Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis. JAMA Neurology. 70(4). 469–469. 58 indexed citations
15.
Bayas, Antonios, Ralf Gold, & Markus Naumann. (2012). Long-term treatment of Lewis–Sumner syndrome with subcutaneous immunoglobulin infusions. Journal of the Neurological Sciences. 324(1-2). 53–56. 15 indexed citations
16.
Bayas, Antonios, Johann Penzien, & Kerstin Hellwig. (2011). Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis. Acta Neurologica Scandinavica. 124(4). 290–292. 15 indexed citations
17.
Bayas, Antonios, et al.. (2002). Human cerebral endothelial cells are a potential source for bioactive BDNF. Cytokine. 19(2). 55–58. 39 indexed citations
18.
Hummel, Vera, Boris Kallmann, Sabine Wagner, et al.. (2001). Production of MMPs in Human Cerebral Endothelial Cells and Their Role in Shedding Adhesion Molecules. Journal of Neuropathology & Experimental Neurology. 60(4). 320–327. 65 indexed citations
19.
Bayas, Antonios & Peter Rieckmann. (2000). Managing the Adverse Effects of Interferon-?? Therapy in Multiple Sclerosis. Drug Safety. 22(2). 149–159. 50 indexed citations
20.
Paulus, Werner, Antonios Bayas, German Ott, & Wolfgang Roggendorf. (1994). Interphase cytogenetics of glioblastoma and gliosarcoma. Acta Neuropathologica. 88(5). 420–425. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. C. Kieseier Breakdown of academic impact, for papers by Neil Minton Breakdown of academic impact, for papers by Sarah Shapiro Breakdown of academic impact, for papers by Amanda Cox Breakdown of academic impact, for papers by Giorgia Teresa Maniscalco Breakdown of academic impact, for papers by Dan Lehmann Breakdown of academic impact, for papers by Hirofumi Ochi Breakdown of academic impact, for papers by Sandrine Wiertlewski Breakdown of academic impact, for papers by Jacqueline Yaouanq Breakdown of academic impact, for papers by Begoña Oliver‐Martos
Rankless by CCL
2026